{"id":51011,"date":"2022-11-17T19:02:55","date_gmt":"2022-11-17T18:02:55","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/gallant-capital-invests-in-lightning-step-to-support-growth\/"},"modified":"2022-11-17T19:02:55","modified_gmt":"2022-11-17T18:02:55","slug":"gallant-capital-invests-in-lightning-step-to-support-growth","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/gallant-capital-invests-in-lightning-step-to-support-growth\/","title":{"rendered":"Gallant Capital Invests in Lightning Step to Support Growth"},"content":{"rendered":"
\n

LOS ANGELES–(BUSINESS WIRE)–Gallant Capital Partners (\u201cGallant\u201d), a Los Angeles-based investment firm, announced that it has completed a strategic growth investment in Lightning Step, a rapidly-growing enterprise software provider purpose-built for the behavioral health industry. Gallant\u2019s investment was made in partnership with Lightning Step\u2019s CEO Kirk Monroe, Chairman Jamison Monroe, and additional investors and members of management, all of whom collectively remain material owners of Lightning Step. Gallant\u2019s investment will be used to expand Lightning Step\u2019s team, accelerate its product roadmap, and make strategic acquisitions.\n<\/p>\n

<\/a><\/p>\n

\n\u201cGallant\u2019s investment, augmented with its operational resources, will serve as a catalyst to propel Lightning Step into the leading EMR provider to the behavioral health industry,\u201d said Kirk Monroe, CEO of Lightning Step. \u201cWe have been thoroughly impressed with the Gallant team and we are excited for what lies ahead for Lightning Step\u2019s team, product, and customers.\u201d\n<\/p>\n

\n\u201cLightning Step has built a great mission-critical product for its customers, driven by a relentless focus on customer experience and a deep understanding of the behavioral health industry\u2019s pain points,\u201d added Jon Gimbel, Partner at Gallant. \u201cWe believe the entire industry would benefit from using Lightning Step\u2019s purpose-built, all-in-one technology solution. We are thrilled to be in partnership with the entire Lightning Step team and look forward to contributing to the company\u2019s continued growth.\u201d\n<\/p>\n

\nTerms of Gallant\u2019s investment were not disclosed.\n<\/p>\n

\nAbout Lightning Step<\/b>\n<\/p>\n

\nFounded by former operators, Lightning Step offers an all-in-one software platform including electronic medical records, revenue cycle management, and customer relationship management technology. Since its founding in 2014, Lightning Step has grown organically and through the acquisitions of Ava Billing, a specialized revenue cycle management provider focused on the behavioral health industry, and ZenCharts, a cloud-based electronic medical records software provider for behavioral health providers. Lightning Step is committed to helping its hundreds of customers reduce overhead, manage admissions, and improve billing and collections to allow providers to focus on what matters \u2013 providing quality care to its patients. For more information, please visit: www.lightningstep.com<\/a>.\n<\/p>\n

\nAbout Gallant Capital Partners<\/b>\n<\/p>\n

\nGallant Capital Partners is a private equity firm that invests in technology, business services, and industrial companies. Gallant executes on an operationally focused investment strategy with a priority on partnering closely with companies that can benefit from its extensive industry relationships and operating expertise. The firm partners with owners, founders, and management teams to maximize value and drive long-term, sustainable growth for its portfolio companies. Gallant was founded in 2018 and is headquartered in Los Angeles. For more information, please visit: www.gallantcapital.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nKendall Corso | Marketing Manager at Lightning Step | 561.901.4138 | kendall.corso@lightningstep.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

LOS ANGELES–(BUSINESS WIRE)–Gallant Capital Partners (\u201cGallant\u201d), a Los Angeles-based investment firm, announced that it has completed a strategic growth investment in Lightning Step, a rapidly-growing enterprise software provider purpose-built for the behavioral health industry. Gallant\u2019s investment was made in partnership with Lightning Step\u2019s CEO Kirk Monroe, Chairman Jamison Monroe, and additional investors and members of … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-51011","6":"format-standard","7":"category-industry"},"yoast_head":"\nGallant Capital Invests in Lightning Step to Support Growth - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/gallant-capital-invests-in-lightning-step-to-support-growth\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Gallant Capital Invests in Lightning Step to Support Growth - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"LOS ANGELES–(BUSINESS WIRE)–Gallant Capital Partners (\u201cGallant\u201d), a Los Angeles-based investment firm, announced that it has completed a strategic growth investment in Lightning Step, a rapidly-growing enterprise software provider purpose-built for the behavioral health industry. Gallant\u2019s investment was made in partnership with Lightning Step\u2019s CEO Kirk Monroe, Chairman Jamison Monroe, and additional investors and members of ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/gallant-capital-invests-in-lightning-step-to-support-growth\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-17T18:02:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221117005976\/en\/1641877\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gallant-capital-invests-in-lightning-step-to-support-growth\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gallant-capital-invests-in-lightning-step-to-support-growth\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Gallant Capital Invests in Lightning Step to Support Growth\",\"datePublished\":\"2022-11-17T18:02:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gallant-capital-invests-in-lightning-step-to-support-growth\\\/\"},\"wordCount\":450,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gallant-capital-invests-in-lightning-step-to-support-growth\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221117005976\\\/en\\\/1641877\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gallant-capital-invests-in-lightning-step-to-support-growth\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gallant-capital-invests-in-lightning-step-to-support-growth\\\/\",\"name\":\"Gallant Capital Invests in Lightning Step to Support Growth - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gallant-capital-invests-in-lightning-step-to-support-growth\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gallant-capital-invests-in-lightning-step-to-support-growth\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221117005976\\\/en\\\/1641877\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-11-17T18:02:55+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gallant-capital-invests-in-lightning-step-to-support-growth\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gallant-capital-invests-in-lightning-step-to-support-growth\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gallant-capital-invests-in-lightning-step-to-support-growth\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221117005976\\\/en\\\/1641877\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221117005976\\\/en\\\/1641877\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gallant-capital-invests-in-lightning-step-to-support-growth\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Gallant Capital Invests in Lightning Step to Support Growth\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Gallant Capital Invests in Lightning Step to Support Growth - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/gallant-capital-invests-in-lightning-step-to-support-growth\/","og_locale":"en_US","og_type":"article","og_title":"Gallant Capital Invests in Lightning Step to Support Growth - Pharma Trend","og_description":"LOS ANGELES–(BUSINESS WIRE)–Gallant Capital Partners (\u201cGallant\u201d), a Los Angeles-based investment firm, announced that it has completed a strategic growth investment in Lightning Step, a rapidly-growing enterprise software provider purpose-built for the behavioral health industry. Gallant\u2019s investment was made in partnership with Lightning Step\u2019s CEO Kirk Monroe, Chairman Jamison Monroe, and additional investors and members of ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/gallant-capital-invests-in-lightning-step-to-support-growth\/","og_site_name":"Pharma Trend","article_published_time":"2022-11-17T18:02:55+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221117005976\/en\/1641877\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/gallant-capital-invests-in-lightning-step-to-support-growth\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/gallant-capital-invests-in-lightning-step-to-support-growth\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Gallant Capital Invests in Lightning Step to Support Growth","datePublished":"2022-11-17T18:02:55+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/gallant-capital-invests-in-lightning-step-to-support-growth\/"},"wordCount":450,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/gallant-capital-invests-in-lightning-step-to-support-growth\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221117005976\/en\/1641877\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/gallant-capital-invests-in-lightning-step-to-support-growth\/","url":"https:\/\/pharma-trend.com\/en\/gallant-capital-invests-in-lightning-step-to-support-growth\/","name":"Gallant Capital Invests in Lightning Step to Support Growth - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/gallant-capital-invests-in-lightning-step-to-support-growth\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/gallant-capital-invests-in-lightning-step-to-support-growth\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221117005976\/en\/1641877\/21\/logo.jpg","datePublished":"2022-11-17T18:02:55+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/gallant-capital-invests-in-lightning-step-to-support-growth\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/gallant-capital-invests-in-lightning-step-to-support-growth\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/gallant-capital-invests-in-lightning-step-to-support-growth\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221117005976\/en\/1641877\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221117005976\/en\/1641877\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/gallant-capital-invests-in-lightning-step-to-support-growth\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Gallant Capital Invests in Lightning Step to Support Growth"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51011","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=51011"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51011\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=51011"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=51011"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=51011"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}